Precision Medicine Group Acquires ETHOS

Precision Medicine Group Inc. acquired ETHOS Health Communications, a Pennsylvania-based agency that specializes in the interpretation and communication of innovative medical science. The acquisition of ETHOS – which informs physicians, providers and other stakeholders via medical affairs-based and marketing-based scientific content – allows Precision Medicine to offer its clients a significantly expanded cadre of doctoral-level science and medical communications specialists.

During its 15-year operating history, ETHOS has been established as an authority in understanding and translating the science of medicine into high-level strategy and tactical execution. With a track record of long-tenured relationships with major biopharma companies and leading biotech firms, ETHOS established a leadership position in the delivery of strategic scientific and medical communications and training solutions.

Commenting on the acquisition of ETHOS, Precision Medicine Group CEO Mark Clein says, “As medical innovations become increasingly complex, the demand for clarity, insight and compelling communications becomes a fundamental success factor for drug developers seeking to convey the medical and economic benefits of their products. With ETHOS, these developers can better translate their science to the multiple constituents that prescribe, utilize, regulate and insure their products. With this addition, Precision has enhanced our proficiency in demonstrating the clinical value of medical innovations throughout the entire development and commercial life cycle.”

With headquarters in Yardley, Pa., ETHOS (ethosh.com) has more than 120 employees, including over 40 with doctoral degrees in science. ETHOS Cofounder and President Anita O’Connor joins the leadership team of Precision Value & Health. According to O’Connor, “We are very happy to be joining the Precision family and partnering with other Precision teams to provide the highest level of expertise to help our clients achieve their objectives and to bring the best science and medicine to patients and healthcare professionals. Our company culture and mission align very closely with Precision’s, and we are very excited about the added value we can now offer both existing and new clients.”

Fairmount Partners, a leading investment bank worldwide for pharma, device and related service businesses, acted as exclusive financial advisor to ETHOS.

Formed during 2012, Precision Medicine Group (precisionmedicinegrp.com) is a specialized services company supporting next-generation approaches to drug development and commercialization. The company provides an integrated infrastructure that supports pharma and life sciences firms as they develop new products in the age of precision medicine. Precision Medicine has headquarters in Bethesda, Md., and offices throughout North America and Europe.